Sirona Biochem Corp. (CVE:SBM – Get Free Report)’s stock price fell 16.7% on Wednesday . The company traded as low as C$0.05 and last traded at C$0.05. 113,000 shares were traded during trading, an increase of 91% from the average session volume of 59,069 shares. The stock had previously closed at C$0.06.
Sirona Biochem Trading Down 16.7 %
The firm has a market cap of C$12.84 million, a price-to-earnings ratio of -5.00 and a beta of -0.03. The firm’s 50-day moving average is C$0.06 and its 200-day moving average is C$0.06. The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21.
Sirona Biochem Company Profile
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Further Reading
- Five stocks we like better than Sirona Biochem
- What Does Downgrade Mean in Investing?
- Oklo’s Fuel Partnership Strengthens Bullish Case for Stock
- Buy P&G Now, Before It Sets A New All-Time High
- SLB: Pioneering the Shift from Oil Services to Tech Solutions
- Investing in the High PE Growth Stocks
- Apple Swings to Outperformer: Is It a Buy Ahead of Earnings?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
